Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection

Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Nov 3, 1999

Keywords

ClinConnect Summary

This clinical trial is looking into how to evaluate, treat, and monitor patients who have or may have parasitic infections, such as malaria, intestinal worms, and other related conditions. The study aims to provide standard medical care and follow-up to ensure that patients receive the appropriate treatment for their specific needs.

To participate in this study, individuals must be at least 3 years old and have signs that suggest a parasitic infection. Those who join will undergo a physical exam and various tests, including blood, stool, or urine tests. They may also have other assessments like x-rays or heart tests, depending on their situation. Participants can expect regular check-ups to see how they are responding to treatment, and if necessary, they may be referred to other studies that better suit their condition. Overall, this trial focuses on providing care based on established medical practices without introducing any new experimental treatments.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• • Age 3 or over.
• • Access to a primary medical care provider outside of the NIH
• • Clinical evidence suggestive of a parasitic infection
• EXCLUSION CRITERIA:
• • Less than 3 years of age
• • No evidence suggestive of a parasitic infection